Putnam Investments LLC Bristol Myers Squibb CO Transaction History

Putnam Investments LLC

$73 Billion
Q4 2023

A detailed history of Putnam Investments LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Putnam Investments LLC holds 153,936 shares of BMY stock, worth $8.33 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

153,936

Previous 120,912 27.31%

Holding current value

$8.33 Million

Previous $7.02 Million 12.56%

% of portfolio

0.01%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$48.48 - $57.85 $1.6 Million - $1.91 Million	33,024 Added 27.31%	153,936 $7.9 Million
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $17.2 Million - $19.2 Million	-296,462 Reduced 71.03%	120,912 $7.02 Million
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $1.16 Million - $1.29 Million	-18,181 Reduced 4.17%	417,374 $26.7 Million
Q1 2023 May 22, 2023	SELL	$65.71 - $74.53 $1.37 Million - $1.55 Million	-20,818 Reduced 4.56%	435,555 $30.2 Million
Q4 2022 Feb 14, 2023	SELL	$68.48 - $81.09 $338,702 - $401,071	-4,946 Reduced 1.07%	456,373 $32.8 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $201 - $118,871	-1,547 Reduced 0.33%	461,319 $32.8 Million
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $14.3 Million - $15.7 Million	196,365 Added 73.68%	462,866 $35.6 Million
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $71.2 Million - $85.4 Million	-1,158,133 Reduced 81.29%	266,501 $19.5 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $5.24 Million - $6.11 Million	97,775 Added 7.37%	1,424,634 $88.8 Million
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $29.7 Million - $34.8 Million	-502,260 Reduced 27.46%	1,326,859 $78.5 Million
Q2 2021 Aug 16, 2021	BUY	$61.91 - $67.42 $3.3 Million - $3.6 Million	53,327 Added 3.0%	1,829,119 $122 Million
Q1 2021 May 17, 2021	BUY	$59.34 - $66.74 $24.3 Million - $27.4 Million	409,974 Added 30.02%	1,775,792 $112 Million
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $18.8 Million - $21.3 Million	325,679 Added 31.31%	1,365,818 $84.7 Million
Q3 2020 Nov 16, 2020	SELL	$57.43 - $63.64 $7.39 Million - $8.18 Million	-128,609 Reduced 11.0%	1,040,139 $62.7 Million
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $14.8 Million - $17.3 Million	270,655 Added 30.14%	1,168,748 $68.7 Million
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $13.9 Million - $20.2 Million	-299,789 Reduced 25.03%	898,093 $50.1 Million
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $22.5 Million - $29.4 Million	457,824 Added 61.86%	1,197,882 $76.9 Million
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $4.61 Million - $5.46 Million	-107,724 Reduced 12.71%	740,058 $37.5 Million
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $20.7 Million - $22.9 Million	-464,489 Reduced 35.4%	847,782 $38.4 Million
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $43.2 Million - $51.5 Million	957,482 Added 269.87%	1,312,271 $62.6 Million
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $60.6 Million - $78.5 Million	-1,242,207 Reduced 77.78%	354,789 $18.4 Million
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $6.21 Million - $7 Million	-112,481 Reduced 6.58%	1,596,996 $99.1 Million
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $51.1 Million - $63.7 Million	-1,011,883 Reduced 37.18%	1,709,477 $94.6 Million
Q1 2018 May 15, 2018	BUY	$59.92 - $68.98 $98.4 Million - $113 Million	1,642,115 Added 152.15%	2,721,360 $172 Million
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $34.7 Million - $37.8 Million	579,158 Added 115.81%	1,079,245 $66.1 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $27.6 Million - $31.9 Million	500,087	500,087 $31.9 Million

Others Institutions Holding BMY

# of Institutions

2,477

Shares Held

1.51B

Call Options Held

29.6M

Put Options Held

32.1M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $115B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.

Account

Putnam Investments LLC Bristol Myers Squibb CO Transaction History